VOR BIOPHARMA INC's ticker is VOR and the CUSIP is 929033108. A total of 60 filers reported holding VOR BIOPHARMA INC in Q1 2023. The put-call ratio across all filers is 0.07 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,747,724 | -31.4% | 3,182,889 | 0.0% | 0.04% | -25.5% |
| Q2 2023 | $9,835,127 | -42.6% | 3,182,889 | 0.0% | 0.06% | -53.0% |
| Q1 2023 | $17,123,943 | -19.1% | 3,182,889 | 0.0% | 0.12% | +18.2% |
| Q4 2022 | $21,166,212 | +520.3% | 3,182,889 | +271.3% | 0.10% | +395.0% |
| Q3 2022 | $3,412,000 | -19.9% | 857,308 | 0.0% | 0.02% | -69.7% |
| Q2 2022 | $4,261,000 | -17.7% | 857,308 | 0.0% | 0.07% | +4.8% |
| Q1 2022 | $5,178,000 | -48.0% | 857,308 | 0.0% | 0.06% | -37.6% |
| Q4 2021 | $9,962,000 | -3.3% | 857,308 | +30.4% | 0.10% | +134.9% |
| Q3 2021 | $10,307,000 | -5.6% | 657,308 | +12.2% | 0.04% | -29.5% |
| Q2 2021 | $10,923,000 | -56.7% | 585,667 | 0.0% | 0.06% | -55.5% |
| Q1 2021 | $25,242,000 | – | 585,667 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 5AM Venture Management, LLC | 6,361,723 | $73,923,000 | 13.88% |
| RA Capital Management | 11,120,973 | $129,226,000 | 2.28% |
| Paradigm Biocapital Advisors LP | 629,342 | $7,313,000 | 2.09% |
| OUP Management Co., LLC | 374,714 | $4,354,000 | 1.96% |
| JOHNSON & JOHNSON | 1,074,658 | $12,488,000 | 1.42% |
| Sarissa Capital Management LP | 707,010 | $8,215,000 | 0.71% |
| Woodline Partners LP | 1,111,123 | $12,911,000 | 0.18% |
| Artal Group S.A. | 550,000 | $6,391,000 | 0.17% |
| Orbimed Advisors | 833,333 | $9,683,000 | 0.12% |
| Laurion Capital Management LP | 857,308 | $9,962,000 | 0.10% |